Identifying niche factors regulating distinct properties of AT2 stem cells
识别调节 AT2 干细胞独特特性的生态位因子
基本信息
- 批准号:9576667
- 负责人:
- 金额:$ 56.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-22 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAdult Respiratory Distress SyndromeAgingAlveolarAutomobile DrivingBindingBiochemistryBronchoscopyCell DeathCell ProliferationCell TransplantationCell divisionCellsChronicChronic Obstructive Airway DiseaseCuesDataDiagnosisDiseaseDisease ProgressionElderlyEnvironmentEpidermal Growth Factor ReceptorEpithelialEpithelial CellsFailureFibroblastsFosteringFunctional disorderGasesGoalsGrowthHumanImmuneInjuryIntegrinsKnowledgeLeadLearningLifeLigandsLongevityLungLung CapacityLung diseasesMaintenanceMapsMedicalMinorMitogensModelingMolecularMorbidity - disease rateMusNatural regenerationOrganParacrine CommunicationPathologyPatientsPharmacologyPneumoniaPopulationProductionProliferatingPropertyRNARegulationResearchResolutionRespiratory FailureRespiratory physiologyRoleSignal PathwaySignal TransductionSignaling MoleculeSiteSmokingStem cellsSurfaceTestingTherapeuticTimeTissuesTransplantationWNT Signaling PathwayWorkalveolar type II cellautocrinebasecell behaviorcell injurydimeridiopathic pulmonary fibrosisimprovedin vivoinjuredlung injurylung regenerationmortalitynew technologynovelparacrinepreventprogramsreceptorreconstitutionrepairedresilienceresponseresponse to injurysingle cell analysissingle cell technologystem cell biologytherapeutic development
项目摘要
PROJECT SUMMARY
A number of serious respiratory diseases cause problems with gas exchange, which is the principal function of
the lungs. Some of these are sudden in onset, like lung injury from a severe pneumonia, while others develop
over long periods of time, like COPD and Idiopathic Pulmonary Fibrosis (IPF). There is some evidence that the
chronic forms of respiratory failure result from loss of the capacity of the lungs to maintain themselves, in part
due to dysfunction of resident lung stem cells that normally perform this role. Therefore, discovering the
specific molecular and cellular mechanisms by which lung stem cells are regulated throughout life may be
helpful for understanding how COPD and IPF develop. Achieving this deep level of understanding about lung
stem cell regulation may lead to improved strategies to predict, diagnose, and even pharmacologically treat
such diseases. Furthermore, given the easy accessibility of the lung via medical bronchoscopy, it is an ideal
organ to target with the delivery of healthy stem cells that might prevent disease progression or even produce
improvement if they can be successfully transplanted into diseased lungs. We have found that one of the
functional cells in the gas exchange region, the alveolar type II (AT2) cell, acts as a stem cell for mouse lung
throughout the lifespan, and identified several factors that regulate its activity. The AIMS of this proposal are to
expand our understanding of how these stem cells are regulated by studying the local environment that
provides the signals that control their activity, including proliferation and differentiation. We will investigate
three specific and distinct aspects of the stem cell behavior, including how it is induced to proliferate to
generate new cells, how it attains the capacity to transiently regulate itself in response to injury, and whether
the regulatory environment is as or more important than the stem cell itself for maintaining the lungs over the
lifespan. Our findings will significantly deepen our understanding of precisely how these lung stem cells can be
deliberately manipulated to generate large numbers suitable for cell transplantation, or by pharmacologically
driving their activity for therapeutic 're-growth' purposes.
项目概要
许多严重的呼吸系统疾病会导致气体交换出现问题,而气体交换是呼吸系统的主要功能。
肺部。其中一些是突然发作的,例如严重肺炎导致的肺损伤,而另一些则是发展而来
长期患病,如慢性阻塞性肺病 (COPD) 和特发性肺纤维化 (IPF)。有一些证据表明
慢性呼吸衰竭的部分原因是肺部自我维持能力丧失
由于通常执行此功能的常驻肺干细胞功能障碍。因此,发现
肺干细胞在整个生命过程中受到调节的特定分子和细胞机制可能是
有助于了解 COPD 和 IPF 的发展过程。实现对肺的深入了解
干细胞调节可能会导致预测、诊断甚至药物治疗策略的改进
此类疾病。此外,鉴于通过医用支气管镜可以轻松到达肺部,它是一种理想的选择
输送健康干细胞的目标器官可能会阻止疾病进展,甚至产生
如果它们能够成功移植到患病的肺部,情况就会有所改善。我们发现其中之一
气体交换区域的功能细胞,即肺泡 II 型 (AT2) 细胞,充当小鼠肺的干细胞
整个生命周期,并确定了调节其活动的几个因素。该提案的目的是
通过研究当地环境来扩大我们对这些干细胞如何调节的理解
提供控制其活动的信号,包括增殖和分化。我们将调查
干细胞行为的三个具体且不同的方面,包括如何诱导其增殖
产生新细胞,它如何获得短暂调节自身以响应损伤的能力,以及是否
对于维持肺部的正常运转而言,调节环境与干细胞本身一样重要或更重要。
寿命。我们的研究结果将显着加深我们对这些肺干细胞究竟如何发挥作用的理解。
故意操纵以产生大量适合细胞移植的细胞,或通过药理学
驱动他们的活动以达到治疗“再生长”的目的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tushar Jasubhai DESAI其他文献
Tushar Jasubhai DESAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tushar Jasubhai DESAI', 18)}}的其他基金
Cellular and molecular mechanisms of alveolar repair
肺泡修复的细胞和分子机制
- 批准号:
10750085 - 财政年份:2023
- 资助金额:
$ 56.28万 - 项目类别:
Identifying niche factors regulating distinct properties of AT2 stem cells
识别调节 AT2 干细胞独特特性的生态位因子
- 批准号:
9767857 - 财政年份:2018
- 资助金额:
$ 56.28万 - 项目类别:
Identifying niche factors regulating distinct properties of AT2 stem cells
识别调节 AT2 干细胞独特特性的生态位因子
- 批准号:
10178079 - 财政年份:2018
- 资助金额:
$ 56.28万 - 项目类别:
Single Cell Profiling and In Vivo Cellular Interrogation of Alveolar Stem Cells
肺泡干细胞的单细胞分析和体内细胞分析
- 批准号:
9130386 - 财政年份:2015
- 资助金额:
$ 56.28万 - 项目类别:
Development and maintenance of the alveolar type 1 cell
肺泡 1 型细胞的发育和维持
- 批准号:
8207255 - 财政年份:2008
- 资助金额:
$ 56.28万 - 项目类别:
Development and maintenance of the alveolar type 1 cell
肺泡 1 型细胞的发育和维持
- 批准号:
7386391 - 财政年份:2008
- 资助金额:
$ 56.28万 - 项目类别:
Development and maintenance of the alveolar type 1 cell
肺泡 1 型细胞的发育和维持
- 批准号:
7754452 - 财政年份:2008
- 资助金额:
$ 56.28万 - 项目类别:
Development and maintenance of the alveolar type 1 cell
肺泡 1 型细胞的发育和维持
- 批准号:
8011694 - 财政年份:2008
- 资助金额:
$ 56.28万 - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Cellular and molecular mechanisms of alveolar repair
肺泡修复的细胞和分子机制
- 批准号:
10750085 - 财政年份:2023
- 资助金额:
$ 56.28万 - 项目类别:
Novel treatment for respiratory distress due to SARS-CoV2 infection
治疗 SARS-CoV2 感染引起的呼吸窘迫的新疗法
- 批准号:
10284733 - 财政年份:2021
- 资助金额:
$ 56.28万 - 项目类别:
Identifying niche factors regulating distinct properties of AT2 stem cells
识别调节 AT2 干细胞独特特性的生态位因子
- 批准号:
9767857 - 财政年份:2018
- 资助金额:
$ 56.28万 - 项目类别:
Identifying niche factors regulating distinct properties of AT2 stem cells
识别调节 AT2 干细胞独特特性的生态位因子
- 批准号:
10178079 - 财政年份:2018
- 资助金额:
$ 56.28万 - 项目类别: